Integra Lifesciences Holdings Corp (NASDAQ: IART) is -27.51% lower on its value in year-to-date trading and has touched a low of $14.45 and a high of $32.66 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IART stock was last observed hovering at around $16.39 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $16.44, the stock is -4.08% and -19.15% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing 0.31% at the moment leaves the stock -25.00% off its SMA200. IART registered -43.78% loss for a year compared to 6-month gain of -14.91%. The firm has a 50-day simple moving average (SMA 50) of $20.3352 and a 200-day simple moving average (SMA200) of $21.9212.
The stock witnessed a -23.92% loss in the last 1 month and extending the period to 3 months gives it a -37.59%, and is -1.56% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.31% over the week and 7.08% over the month.
Integra Lifesciences Holdings Corp (IART) has around 4396 employees, a market worth around $1.27B and $1.61B in sales. Fwd P/E is 6.05. Profit margin for the company is -0.43%. Distance from 52-week low is 13.77% and -49.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.24%).
with sales reaching $381.17M over the same period.The EPS is expected to shrink by -3.83% this year, but quarterly earnings will post 4.28% year-over-year. Quarterly sales are estimated to grow 3.33% in year-over-year returns.
319.0 institutions hold shares in Integra Lifesciences Holdings Corp (IART), with institutional investors hold 108.77% of the company’s shares. The shares outstanding are 77.17M, and float is at 66.10M with Short Float at 5.23%. Institutions hold 93.23% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.25 million shares valued at $327.92 million. The investor’s holdings represent 14.5376 of the IART Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 7.77 million shares valued at $226.5 million to account for 10.0412 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 5.5 million shares representing 7.1032 and valued at over $160.23 million, while WELLINGTON MANAGEMENT GROUP LLP holds 5.0208 of the shares totaling 3.89 million with a market value of $113.25 million.
Integra Lifesciences Holdings Corp (IART) Insider Activity
The most recent transaction is an insider sale by Schwartz Eric, the company’s EVP, Chief Legal Officer & Sec. SEC filings show that Schwartz Eric sold 4,070 shares of the company’s common stock on Dec 03 ’24 at a price of $24.59 per share for a total of $0.1 million. Following the sale, the insider now owns 59511.0 shares.
Still, SEC filings show that on Dec 02 ’24, McBreen Michael J. (EVP & President, CSS) disposed off 1,700 shares at an average price of $24.16 for $41064.0. The insider now directly holds 56,182 shares of Integra Lifesciences Holdings Corp (IART).
